Specific binding of 1251I-labelled human somatotropin was demonstrated in microsomal membranes (microsomes) from rat and rabbit kidneys. Female rabbit kidney microsomes showed the highest binding activity and were used for further study. The association of 1251I-labelled human somatotropin was timeand temperature-dependent and the binding reaction was reversible. Scatchard analysis of saturation data indicated a dissociation equilibrium constant, KD, of 56pM and a binding capacity of 37fmol per mg of protein. Similar results were obtained from competition experiments. Binding of 121I-labelled human somatotropin to the microsomes was specifically inhibited by hormones with lactogenic activity. The binding sites, as well as 1251I-labelled human somatotropin, were not inactivated on incubation. Treatment of the microsomes with trypsin and chymotrypsin decreased the specific binding by over 90%. Preheating of the microsomes at 55 0C for 15 min abolished 50% of the specific binding activity.
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Distribution studies of radioactively labelled somatotropins injected into animals from different species revealed that the kidney was the organ where the highest concentration of radioactivity occurred (Sonenberg et al., 1954; Salmon et aL, 1962; Collipp et al., 1966; Wallace et al., 1972; Retegui-Sardou et al., 1977; Johnson & Maack, 1977) .
On the basis of these studies it has been suggested that somatotropin is removed from blood by glomerular filtration and then subjected to tubular reabsorption with subsequent passage of the intact hormone or its metabolic products back into the blood. A simultaneous effect of the hormone on kidney function may occur during this process (Wallace et al., 1972; Retegui-Sardou et al., 1977) .
Autoradiographic studies demonstrated the localization of somatotropins in the convoluted tubules of the kidney (Mess & Hamori, 1965; De Kretser et al., 1969; Collipp et al., 1966; Stacy et al., 1976) .
Prolactin, which is structurally and functionally related to somatotropin, was also concentrated by the kidney after intravenous injection (Birkinshaw & Falconer, 1972) with localization either in the proximal tubules, as was shown by autoradiographic (Rajaniemi et al., 1974) and doubleantibody (Donatsch & Richardson, 1975) techniques or in the loop of Henle, distal tubule and collecting duct (Evan et al., 1977) .
These findings are consistent with the possible presence of specific binding sites in kidney. In order Vol. 200 to verify this hypothesis the binding of human somatotropin, which possesses growth (Li & Papkoff, 1956) as well as lactogenic (Kleinberg & Frantz, 1971 ) activity, was investigated in rat and rabbit kidney and was characterized in female rabbit kidney microsomes.
Materials and methods Materials
The majority of the hormones and chemicals used in this work were prepared, purified or obtained as indicated by Bonifacino et al. (1981) .
Follitropin and lutropin were obtained from N.I.H., N.I.A.M.D.D. Hormone Distribution Program, Bethesda, MD, U.S.A. and chymotrypsin from bovine pancreas was from Sigma.
Iodination ofhuman somatotropin
125I-labelled somatotropin was prepared as described previously (Bonifacino et al., 1981) .
Crude kidney microsomal preparation
Kidneys were obtained from adult male or adult virgin female New Zealand rabbits (3.0-3.5 kg), and from adult male or adult virgin female rats of the Long-Evans strain (210-250g).
The animals were killed by cervical dislocation and the kidneys quickly removed and processed, or kept at -600C for less than 1 month.
The fresh, or thawed, kidneys were rinsed with a 0.3 M-sucrose/0.5 mM-CaC12/5 mM-Tris/HCl buffer, pH7.0, and homogenized for 90s at 0°C in 6vol.
(v/w) of the same buffer, in a Sorvall Omni-Mixer at a speed setting of 5. The homogenate was centrifuged for 20min at 15000g (raV. 7.4cm) at 40C in a Sorvall RC2-B centrifuge with an SS34 rotor. The supernatant was centrifuged for 90 min at 100 OOOg (rav. 5.9 cm) at 40C in a type 40 rotor of a Spinco model L ultracentrifuge and the pellet was suspended in 25mm-Tris/HCl buffer, pH 7.0, with a Dounce-type homogenizer. A sample of the suspension was solubilized by heating for 30min at 1000C in 1 M-NaOH and the protein concentration was determined by the method of Lowry et al. (1951) with bovine serum albumin as standard.
The crude microsomal suspension, fractionated into 1-2 ml portions, was kept at -60°C until used. Measurement of 125I-labelled human somatotropin binding Binding assays were performed by incubating, for 16h at 250C, 1.6-2.2ng of 125I-labelled human somatotropin (80000-100000c.p.m.) with 400-600,ug of microsomal proteins in a total volume of 0.5ml. Plastic tubes were used and the incubation medium consisted of 25 mM-Tris/HCl (pH 7.0)/ lOmM-CaCl2/0.08% bovine serum albumin. In each determination, tubes containing the same mixture described plus 5,ug of unlabelled human somatotropin were incubated in parallel.
The binding was terminated by dilution with 4ml of cold incubation medium and centrifugation at 1400g (r8.v 15 cm) for 25min at 40C. The supernatant was discarded and the tubes were kept inverted on filter paper for at least 12h at 40C before being counted for radioactivity.
All determinations were carried out in triplicate and the results are expressed as mean values. The standard deviation was always less than 3%. The percentage of specific binding was calculated as (C1-C2) x 100/A where C1 is the amount of radioactivity bound in the absence of unlabelled human somatotropin, C2 is the amount of radioactivity bound in the presence of 5,g of unlabelled human somatotropin and A is the total amount of radioactivity initially placed in each tube.
Results
Specific binding of 125I-labelled human somatotropin to rat and rabbit kidney microsomes Table 1 shows the binding activity of 125I-labelled human somatotropin to kidney microsomes from adult rats or rabbits.
The specific binding to the microsomes preparations varies with the sex of the animals used; the binding was higher in female rabbit membranes The kidneys were processed and analysed as indicated in the Materials and methods section. The binding of 125I-labelled human somatotropin to the 100lOOg supernatant was measured by the poly-(ethylene glycol) precipitation method (Bonifacino et al., 1981) . The specific activity is expressed as indicated in Table 1 than in male ones, whereas the inverse situation was observed in rats. Microsomes from female rabbits were selected for further study.
Distribution of 125I-labelled human somatotropin
binding activity in subcellular fractions offemale rabbit kidney.
The binding activity of 125I-labelled human somatotropin to subcellular fractions obtained by homogenization and differential centrifugation of renal tissue is shown in Table 2 . The crude microsomal suspension obtained with the 100lOOg pellet showed the highest specific activity and was used in this study.
Effect of membrane protein concentration on the specific binding of'251-labelled human somatotropin
The specific binding increases in direct proportion to the membrane protein concentration (Fig. 1 
Kinetics ofassociation
The specific binding of '25I-labelled human somatotropin to kidney microsomes is timeand temperature-dependent, as shown in Fig. 2 . At 25°C maximal binding is obtained within 15h and this value remains constant for at least 30h. At 150C, or at 40C, equilibrium is not reached in 30h, the longest incubation time explored. At 370C the association progresses faster than at 250C and reaches essentially the same equilibrium level; the binding then decreases, probably due to inactivation or degradation of the binding sites, the hormone, or both.
Kinetic analysis of the values obtained at 250C shows that the association reaction obeys secondorder kinetics. The mean value of the association rate constant (k,j) at 250C, obtained from three similar experiments, was (1.1 +0.4) x 107mol-h litre * min-'.
Kinetics ofdissociation
The specific binding of 125I-labelled human somatotropin to kidney microsomes is reversible:
approx. 50% of specifically bound hormone is dissociated after 30h at 250C (Fig. 3 ). The rate of this process is unaffected by the presence of unlabelled hormone (2500-fold molar excess). 125I-labelled human somatotropin (80000c.p.m.) was incubated with 500,ug of microsomal protein under the conditions described in the Materials and methods section. The pellets obtained were suspended in 4.0 ml of incubation medium (@) or 4.0 ml of incubation medium plus 5,ug of unlabelled human somatotropin (0), and then were incubated at 250C for a variety of time intervals, before centrifuging at 1400g for 25min at 40C. The new pellets were counted for radioactivity. relationship is obtained, indicating first-order kinetics. The mean value of the dissociation rate constant (k-1) obtained from two similar experiments was 3.8 x 10-4min-'.
Effect of hormone concentration on the specific binding Fig. 4(a) shows that the specific binding of 12511 labelled human somatotropin to the microsomes is a saturable process, whereas the non-specific binding increases linearly. Scatchard (1949) analysis of the binding data from Fig. 4 (a) yields a linear plot (Fig. 4b) . The specific binding sites in the microsomes have KD = 56 + 18PM and a binding capacity of 37 + 5 fmol/mg of protein (means + S.D.; n = 5).
Specificity of 1251-labelled human somatotropin binding to rabbit kidney microsomes Fig. 5 shows the inhibition curves obtained when the specific binding of 125I-labelled human somatotropin to the microsomes is challenged by different hormones. Lactogenic hormones, such as ovine prolactin and human choriomammotropin, inhibit the binding of '25I-labelled human somatotropin, although less effectively than does human somatotropin.
The effect observed with bovine somatotropin was minimal, since only a 30% inhibition was observed with a concentration three orders of magnitude higher than an equi-effective dose of human somatotropin. Equine somatotropin and other un- related hormones (follitropin, lutropin and insulin), do not inhibit the specific binding.
Scatchard plots obtained from competition data were also linear. The values of the dissociation equilibrium constant and binding capacity calculated by this procedure were 48 + 1 1 pM and 40 + 3 fmol/ mg respectively. These parameters are similar to those obtained from saturation curves.
When kidney microsomes from adult male rabbits were assayed, the resulting inhibition curves indicated a pattern of specificity similar to that obtained with female animals.
Binding site and '25I-labelled human somatotropin inactivation during incubation
In order to study the inactivation of the binding sites, membranes were pre-incubated for 16 h at 250C under standard conditions. Then '25l-labelled human somatotropin was added and the reaction mixture was incubated for 7h at 25°C. No differences were found in comparison with a sample of microsomes that was not pre-incubated.
The possible degradation of the hormone was investigated by incubating 125I-labelled human somatotropin (200000c.p.m.) with the microsomal suspension (600,ug of protein) for 16h at 250C in the usual medium. The integrity of the labelled hormone was analysed by chromatography on Sephadex G-100 (Bonifacino et al., 1978) and by its ability to rebind to fresh microsomes.
The gel filtration experiments were done as follows. The bound hormone was dissociated by adjusting the incubation medium to pH 3.0 with 1 M-HCI. After 5min at 25 0C the reaction mixture was neutralized (pH 7.0) with 1 M-NaOH and the membranes were eliminated by centrifugation at 1400g for 25min at 40C. More than 90% of the hormone in the complex was released by this treatment. The supernatant, which contained unbound as well as dissociated hormone, was submitted to chromatography on Sephadex G-100. No indications of degradation were found in the elution pattern.
The rebinding experiments were carried out in the following way. Reaction mixture that had been incubated for 16 h at 25 0C was centrifuged at 1400g for 25min at 40C. The supernatant (free labelled hormone) was kept for later studies. The pellet (bound labelled hormone) was washed with 25mM-Tris / HCI (pH 7.0)/ lOmM-CaCl2 / 0.08% bovine serum albumin and then was resuspended in the same medium adjusted to pH 3.0 with 1 M-HCI. After 5min at 250C the suspension was neutralized (pH 7.0) with 1 M-NaOH and the dissociated '25I-labelled hormone was obtained by centrifugation. with fresh microsomal suspension (140,ug of protein) under standard conditions. The percentages of specific binding were 6.7 + 0.3, 6.4 + 0.8 and 6.5 + 0.7 (means + S.D.; n = 3) respectively. The conclusion was drawn that on incubation with the microsomes the labelled hormone is neither degraded nor inactivated.
Solutions
Effect ofdifferent enzymic treatments on the binding activity ofthe microsomal membranes
To explore the chemical nature of the binding sites, the microsomes were treated with different enzymes (Table 3 ). Trypsin and chymotrypsin caused more than a 90% decrease in the specific binding, whereas treatment with neuraminidase or phospholipase C had no effect. Phospholipase A2 caused a 40% increase in the specific binding.
Sensitivity ofthe binding sites to heat treatment Fig. 6 shows that the binding sites in the microsomes are unaffected by treatment for 15min at 45°C. Any further increase in the temperature rapidly inactivates the specific binding remains at 550C and 0% at 65°C.
These results, together with the repo tion of the binding sites by trypsin or action, suggest the importance of a ponent in the human somatotropin bind
Discussion
The present studies demonstrate the specific binding sites for 125I-labelled ht tropin in microsomal membranes fi rabbit kidneys. The characteristics oi reaction were further investigated in microsomes, which showed the hig activity.
The interaction displayed many of t required to define a hormone receptor, affinity, structural specificity, saturat versibility (Cuatrecasas, 1974; Cu Hollenberg, 1976; Posner, 1975; Kahi & Dufau, 1976 .
The kinetics of the association proc order and analysis of the dissocia indicates that this process is first results, together with the linear n; Scatchard plots whether saturation oi data are used, strongly suggest the homogeneity of the binding sites studied.
It is well known that '25I-labelled human somatotropin can be bound by two types of binding sites, which, according to their specificity were called 'somatogenic' (Ranke et al., 1976a,b) and 'lactogenic' Postel-Vinay, 1976) .
Binding of 125I-labelled human somatotropin to the somatogenic sites is specifically inhibited by hormones possessing growth activity, whereas hormones with lactogenic activity only compete for binding to the lactogenic sites (Tsushima & Friesen, 1973; Posner et al., 1974; Kelly et al., 1974; Herington et al., 1976; Ranke et al., 1976a,b; Postel-Vinay, 1976; Postel-Vinay & Desbuquois, 1977) . The heterogeneity of both somatogenic (Turyn et al., 1976; Posner, 1976; Hughes, 1979;  60 80 Baxter et al., 1980) and lactogenic (Herington et al., 1976) sites has been postulated. Furthermore, some studies indicated an overlapping of their specificity. n, 1tml)twas Thus, prolactin recognizes somatogenic binding indicated, sites (Ranke et al., 1976a; Waters & Friesen, 1979;  ibating 1251 -Cadman & Wallis, 1980 Wallis & Cadman, 1981 ) c.p.m.) with and bovine somatotropin can be bound by lactogenic tion as indi-sites (Ranke et al., 1976a; Cadman & Wallis, 1980 ; ,ection. The Wallis & Cadman, 1981) , although with a lower f binding of affinity than that of the corresponding hormones. ntrol).
These phenomena have impeded a clear distinction between the two classes of sites in some systems. However, the specificity studies performed with our preparation showed the presence of binding activity; 50% sites which interact only with lactogenic hormones, such as human somatotropin, ovine prolactin and orted inactivahuman choriomammotropin. The existence of a chymotrypsin small proportion of somatogenic binding sites, protein com-undetectable under the present experimental condiling sites.
tions, cannot be ruled out. It is noteworthy that the binding sites described in this paper possess one of the highest affinities reported for receptors with similar specificity ( Lactogenic sites were also identified in mouse the properties (Frantz et al., 1974) and rat (Marshall et al., 1975;  such as high Mountjoy et al., 1980) kidneys using '25I-labelled ility and re-ovine prolactin as a ligand. In addition the regulation atrecasas & of these binding sites by dehydration (Marshall et n, 1976; Catt al., 1975) , oestrogens and testosterone (Marshall et al., 1976) , glucocorticoids (Marshall et al., 1978) .ess is second and thyroid status (Marshall et al., 1979 ) was ition kinetics demonstrated. order. These Treatment of the membranes with phospholipase ature of the A2 causes an increase in the total binding activity. r competition This phenomenon is similar to that reported for the 1981 insulin receptor in liver and fat cell membranes (Cuatrecasas, 1971 ) and for the human somatotropin binding sites in liver microsomes (Du Caju et al., 1978; Sanchez et al., 1979) or isolated hepatocytes (Postel-Vinay & Desbuquois, 1977 ). An increase in binding activity was also achieved by adding Triton X-100 to the membranes (Cuatrecasas, 1972; Bonifacino et al., 1981) . Although a change in affinity cannot be discarded, we favour the view of exposure of masked receptors, either inhibited by phospholipids or occluded into membrane vesicles. At present, the role played by the lactogenic sites in the kidney is unknown. Since this organ is one of the major sites of degradation of somatotropin and prolactin (Retegui-Sardou et al., 1977; Birkinshaw & Falconer, 1972) , it is possible that the binding sites are involved in their catabolism. However, some evidence indicates that these hormones may be important in the regulation of water and electrolyte balance in various mammals, including man. It has been reported that they decrease the urinary excretion of water, sodium and potassium in humans (Biglieri et al., 1961; Horrobin et al., 1971 ), cats (Lockett & Roberts, 1963; Lockett, 1965) and rats (Lees et al., 1964; Lockett & Nail, 1965; Wallin & Lee, 1976) . Similar renal effects have been demonstrated only for prolactin in sheep (Horrobin et al., 1973) and rabbits (Burstyn, 1976) .
Thus, the lactogenic binding sites may represent physiological receptors, involved in the mechanism of regulation of renal function in mammals.
